Skip to content

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new way to enhance treatment plans and practices in an emerging industry.  

Arfinn Med reports screen

The free portal includes four key components:

Reports – generate a report or submit your own patient findings on treatment effectiveness, daily dosage, delivery method and more, specific to patient demographics

Community – connect with a national network of peers and join specialized groups and forums for real-time discussion regarding best practices

Industry News – access news, trends and announcements impacting the medical marijuana industry and physicians’ practices

Resources – tap into assets, such as patient engagement tools that allow physicians to more closely communicate with and monitor treatment progress, and receive discounts for telemedicine software and other products to help your practice grow

Any licensed medical professional is invited to register for the portal for free, regardless of state location and medical marijuana legalization. Additional benefits of registration include: enhanced visibility of your practice through inclusion in our Participating Physicians Directory, and access to medical marijuana patient informational videos to display in your office or waiting room.

If you’re ready to join a nationwide network of licensed medical professionals to learn and share best practices and treatment efficacies for medical marijuana, join Arfinn Med for free today.

Stories you may be interested in

A Message To Our Clients

To Our Clients, First of all, I hope everyone is staying safe and healthy in these unprecedented times.  I want to assure you that Arfinn Med has systems in place to ensure that our workflows are not impacted from having staff work remotely and we will continue to provide the same quality product and customer service…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Older adults and medical marijuana: Reduced stigma and increased use

As a primary care doctor who has incorporated medical cannabis into his practice, it is notable how many silver-haired patients are coming in to discuss the pros and cons of a trial of medical cannabis. These patients range from people in their 60s with kidney failure who can no longer take certain pain medications but…
Read More

Survey of oncologists finds knowledge gap on medical marijuana

As more states legalize medical marijuana, two key groups — researchers whose job is it to understand its benefits and drawbacks, and physicians charged with advising potential users — are struggling to catch up with policymakers. Ilana Braun, an assistant professor of psychiatry at Harvard Medical School and chief of the division of adult psychosocial…
Read More

New study finds cannabis effective for treating migraines

A study published last month in the Journal of Pain found a statistically significant reduction in migraine and headache symptoms and recurrences among patients who used cannabis for treatment.Smoking cannabis reduced the severity and length of migraine episodes by nearly half. Researchers concluded that headache and migraine severity were reduced by nearly 50% after using cannabis. The study, conducted by researchers…
Read More

$2.7 million awarded for medical marijuana research in Colorado

The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More